West Pharmaceutical Services, Inc.

XNYSHealth care

Last traded price · USD

$408.78

+0.44%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $416.46
Previous close: $406.99
Volume: 1.1M
Day's high: $416.46
Day's low: $405.12

In brief

West Pharmaceutical Services, Inc. is a health care company listed on the New York Stock Exchange, valued at about $28.48B.
Its shares closed at $408.78 on 4 Nov 2026, up 42.5% over the past year.
From India you can buy WST in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy West Pharmaceutical Services, Inc. (WST) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole WST share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade WST options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +9.7% (SPY −1.6%, XLV +13.5%). 3 months: +16.5% (SPY −0.4%, XLV +15.5%). 1 year: +42.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: WST, SPY and XLV · as of 4 Nov 2026
6.7% below its 52-week high
Closed at $408.78 on 4 Nov 2026: 6.7% below the 52-week high of $438.27 (29 Oct 2026) and 82.6% above the low of $223.83 (30 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Next ex-dividend date: 10 Nov 2026
$0.26 a share, payable 18 Nov 2026; up 18.2% from the previous $0.22 (ex-date 29 Jul 2026).
Corporate actions record · as of 5 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $408.78 was 10.2% above its 50-day average ($370.98) and 29.5% above its 200-day average ($315.55). It has closed above the 200-day for 150 sessions, since 2 Apr 2026. The 50-day average crossed above the 200-day on 5 May 2026, 127 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.6× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 1.1M shares was 1.6× the average of the 30 sessions before it (666.0K), as the price rose 0.4%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.7%

6 months+30.8%

1 year+42.5%

5 years−5.6%

Newswire

About

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Website

Notable moves

July 24, 2025
+22.78%
February 13, 2025
−38.22%
October 24, 2024
+15.43%

Newswire

About

Website

Notable moves

July 24, 2025
+22.78%
February 13, 2025
−38.22%
October 24, 2024
+15.43%

West Pharmaceutical Services, Inc.

XNYSHealth care

Last traded price · USD

$408.78

+0.44%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.

Day's open: $416.46
Previous close: $406.99
Volume: 1.1M
Day's high: $416.46
Day's low: $405.12

In brief

West Pharmaceutical Services, Inc. is a health care company listed on the New York Stock Exchange, valued at about $28.48B.
Its shares closed at $408.78 on 4 Nov 2026, up 42.5% over the past year.
From India you can buy WST in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy West Pharmaceutical Services, Inc. (WST) shares from India?

Do I need the price of a whole WST share to invest?

How much can I invest in US stocks in a year?

Can I trade WST options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: +9.7% (SPY −1.6%, XLV +13.5%). 3 months: +16.5% (SPY −0.4%, XLV +15.5%). 1 year: +42.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: WST, SPY and XLV · as of 4 Nov 2026
6.7% below its 52-week high
Closed at $408.78 on 4 Nov 2026: 6.7% below the 52-week high of $438.27 (29 Oct 2026) and 82.6% above the low of $223.83 (30 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Next ex-dividend date: 10 Nov 2026
$0.26 a share, payable 18 Nov 2026; up 18.2% from the previous $0.22 (ex-date 29 Jul 2026).
Corporate actions record · as of 5 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $408.78 was 10.2% above its 50-day average ($370.98) and 29.5% above its 200-day average ($315.55). It has closed above the 200-day for 150 sessions, since 2 Apr 2026. The 50-day average crossed above the 200-day on 5 May 2026, 127 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.6× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 1.1M shares was 1.6× the average of the 30 sessions before it (666.0K), as the price rose 0.4%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.7%

6 months+30.8%

1 year+42.5%

5 years−5.6%

Newswire

About

Website

Notable moves

July 24, 2025
+22.78%
February 13, 2025
−38.22%
October 24, 2024
+15.43%

Newswire

About

Website

Notable moves

July 24, 2025
+22.78%
February 13, 2025
−38.22%
October 24, 2024
+15.43%

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

6.7% below its 52-week high

Next ex-dividend date: 10 Nov 2026

Above its 50- and 200-day averages

Volume 1.6× its 30-session average on 4 Nov 2026

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. in brief

Ahead of SPY and its sector fund XLV over 1 year

6.7% below its 52-week high

Next ex-dividend date: 10 Nov 2026

Above its 50- and 200-day averages

Volume 1.6× its 30-session average on 4 Nov 2026